Approval for the expansion of the EluNIR Ridaforolimus Eluting Coronary Stent System product matrix by adding stent length of 38 mm in diameters 2.75, 3.0, 3.5 and 4.0 mm. This device is indicated for improving coronary luminal diameter in patients with symptomatic heart disease due to de novo lesions <=36mm in length in native coronary arteries with reference diameter of 2.50mm to 4.25mm.